MX2018001221A - Pharmaceutical composition with improved storage stability and method for preparing the same. - Google Patents

Pharmaceutical composition with improved storage stability and method for preparing the same.

Info

Publication number
MX2018001221A
MX2018001221A MX2018001221A MX2018001221A MX2018001221A MX 2018001221 A MX2018001221 A MX 2018001221A MX 2018001221 A MX2018001221 A MX 2018001221A MX 2018001221 A MX2018001221 A MX 2018001221A MX 2018001221 A MX2018001221 A MX 2018001221A
Authority
MX
Mexico
Prior art keywords
preparing
pharmaceutical composition
same
storage stability
improved storage
Prior art date
Application number
MX2018001221A
Other languages
Spanish (es)
Inventor
Oh Kim Bong
Chan MIN Bum
Yeong KIM Ji
Rim Kim Hye
Hyo Seo Min
Woong Yi Yil
Jin Kyung Kyu
Jeong Yoon Yoo
Original Assignee
Samyang Biopharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samyang Biopharmaceuticals filed Critical Samyang Biopharmaceuticals
Publication of MX2018001221A publication Critical patent/MX2018001221A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A pharmaceutical composition containing a specific related compound in an amount within a specified limit and a method for preparing the same are provided.
MX2018001221A 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same. MX2018001221A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20150106627 2015-07-28
PCT/KR2016/008267 WO2017018818A1 (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Publications (1)

Publication Number Publication Date
MX2018001221A true MX2018001221A (en) 2018-04-24

Family

ID=57885186

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001221A MX2018001221A (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same.

Country Status (13)

Country Link
EP (1) EP3328435A4 (en)
JP (1) JP2018521103A (en)
KR (1) KR101787451B1 (en)
CN (1) CN106659681A (en)
AU (1) AU2016299546B2 (en)
BR (1) BR112018001725A2 (en)
CA (1) CA2993925A1 (en)
HK (1) HK1249442A1 (en)
IL (1) IL257188A (en)
MX (1) MX2018001221A (en)
RU (1) RU2018107057A (en)
WO (1) WO2017018818A1 (en)
ZA (1) ZA201801188B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102144479B1 (en) * 2018-05-24 2020-08-13 주식회사 덱스레보 Composition for tissue repair treatment and methods of manufacturing the same
KR102251192B1 (en) * 2020-08-07 2021-05-13 주식회사 덱스레보 Composition for tissue repair treatment and methods of manufacturing the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4049588B2 (en) * 2000-05-12 2008-02-20 サムヤン コーポレイション Production method of polymer micelle by phase separation of block copolymer
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
ES2292827T3 (en) * 2001-10-18 2008-03-16 Samyang Corporation COMPOSITION MICELAR POLYMERICA WITH IMPROVED STABILITY.
ATE487134T1 (en) 2007-03-06 2010-11-15 Cell Therapeutics Europe Srl METHOD FOR DETERMINING THE AMOUNT OF CONJUGATED TAXANS IN POLYGLUTAMIC ACID-TAXANE CONJUGATES
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
KR101024742B1 (en) * 2007-12-31 2011-03-24 주식회사 삼양사 Amphiphilic Block Copolymer Micelle Composition Containing Taxane and Manufacturing Process of The Same
WO2009091150A2 (en) * 2007-12-31 2009-07-23 Samyang Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
CN102218027B (en) * 2011-04-22 2014-07-02 上海谊众生物技术有限公司 Polymer micelle lyophilized agent encapsulating insoluble antitumor drug
CN103768013A (en) * 2014-01-17 2014-05-07 丽珠医药集团股份有限公司 Paclitaxel polymer micelle by using refined amphiphilic block copolymer as carrier

Also Published As

Publication number Publication date
EP3328435A4 (en) 2019-03-13
AU2016299546A1 (en) 2018-03-08
CA2993925A1 (en) 2017-02-02
HK1249442A1 (en) 2018-11-02
AU2016299546B2 (en) 2019-05-02
JP2018521103A (en) 2018-08-02
WO2017018818A1 (en) 2017-02-02
ZA201801188B (en) 2018-12-19
EP3328435A1 (en) 2018-06-06
IL257188A (en) 2018-03-29
RU2018107057A3 (en) 2019-08-28
BR112018001725A2 (en) 2018-09-18
KR20170015199A (en) 2017-02-08
CN106659681A (en) 2017-05-10
KR101787451B1 (en) 2017-10-19
RU2018107057A (en) 2019-08-28

Similar Documents

Publication Publication Date Title
EP3523419A4 (en) Compositions and methods for maintaining cell viability
EP3285711A4 (en) Anaerobic blood storage containers
EP3118195A4 (en) Production method for episulfide compound for optical material, episulfide-containing composition, and polymerizable composition including episulfide-containing composition and for use in optical material
IL241046A0 (en) Fertilizer composition and method for preparing the same
EP3219650A4 (en) Double-weighing metering storage hopper
EP3130355A4 (en) Pharmaceutical composition containing pregabalin with improved stability and method for preparing same
EP3342414A4 (en) Agent for enhancing atp in cells
HRP20200104T8 (en) Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
HK1249129A1 (en) Container for cell administration, storage or culturing
EP3555108A4 (en) Hydrogen storage and delivery material
EP3020742A4 (en) Trioxane composition and method for storing same
MX2018001221A (en) Pharmaceutical composition with improved storage stability and method for preparing the same.
MX2018001219A (en) Pharmaceutical composition with improved storage stability and method for preparing the same.
MX2018001222A (en) Pharmaceutical composition with improved storage stability and method for preparing the same.
MX2018001223A (en) Pharmaceutical composition with improved storage stability and method for preparing the same.
EP3395349A4 (en) Nkt cell-activating pharmaceutical composition, method for producing same, and method for storing antigen-presenting cell
AU2016905200A0 (en) Hydrogen storage and delivery material
HK1224131A2 (en) Composition for energy storage, and system thereof
GB2526399B (en) Battery case for lead-acid battery, lead-acid battery using the battery case, and resin composition for the battery case
AU2015901765A0 (en) Improvements in container base